AADI BIOSCIENCE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.91 USD | -0.26% |
|
+7.30% | -5.45% |
| May. 08 | Aadi Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| May. 08 | Earnings Flash (AADI) AADI BIOSCIENCE Reports Q1 Revenue $5.4M | MT |
Chart calendar Aadi Bioscience, Inc.
7.wOn8ZgpuwQJ-jbOaKxd4jFSY1iF1b_ukJDxQsdjpC5M.mK6kVzgYpzQ74ofOTUcMtD_xhlITH8_dEn402LnaZcarvLo3e1ulUTX81A~751381b5cf65937e6c5f06d383de8034
Upcoming events on Aadi Bioscience, Inc.
Past events on Aadi Bioscience, Inc.
| 2024-05-08 08:30 am | Q1 2024 Earnings Call |
| 2024-05-08 08:00 am | Q1 2024 Earnings Release |
| 2024-04-10 09:00 am | American Association for Cancer Research Meeting - Abstract Number: 7196 |
| 2024-04-09 01:30 pm | American Association for Cancer Research Meeting - Abstract Number: 6486 |
| 2024-03-18 02:45 pm | Society of Gynecologic Oncology Meeting - Poster Number: 2126 |
| 2024-03-18 02:45 pm | Society of Gynecologic Oncology Meeting - Poster Number: 2127 |
| 2024-03-17 04:45 pm | Society of Gynecologic Oncology Meeting |
| 2024-03-17 04:15 pm | Society of Gynecologic Oncology Meeting - Poster Number: 1176 |
| 2024-03-13 08:30 am | Q4 2023 Earnings Call |
| 2024-03-13 08:00 am | Q4 2023 Earnings Release |
| 2024-03-04 02:10 pm | TD Cowen Health Care Conference |
| 2024-01-27 02:30 pm | American Society of Clinical Oncology Genitourinary Cancers Symposium |
| 2024-01-27 10:00 am | American Society of Clinical Oncology Genitourinary Cancers Symposium |
| 2024-01-26 08:45 pm | American Society of Clinical Oncology Genitourinary Cancers Symposium |
| 2024-01-26 02:30 pm | American Society of Clinical Oncology Genitourinary Cancers Symposium |
| 2024-01-19 03:30 pm | American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract No: TPS585 |
| 2024-01-19 03:30 pm | American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract No: 558 |
| 2024-01-19 03:30 pm | American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract No: TPS601 |
| 2023-12-14 05:00 pm | PRECISION1 Nab Sirolimus Trial Results Call |
| 2023-11-14 03:30 am | Jefferies London Healthcare Conference |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,12 0,06 1766.67% | 15,2 14,1 8.13% | 24,4 24,1 0.94% | 24,4 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -111 -112 1.13% | -62,7 -63,0 0.47% | -71,9 -72,9 1.36% | -77,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -110 -111 0.66% | -60,5 -62,7 3.44% | -65,8 -67,6 2.79% | -73,5 |
|
Net income Million USD | Released Forecast Spread | -111 -111 0.1% | -60,5 -62,7 3.48% | -65,8 -67,6 2.79% | -73,5 |
|
EPS USD | Released Forecast Spread | -12,4 -6,86 -80.9% | -2,69 -2,94 8.5% | -2,44 -2,49 2.09% | -2,44 |
| Announcement Date | 17/03/22 | 29/03/23 | 13/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2,31 0,42 454.03% | 3,44 3,26 5.52% | 4,25 3,86 9.95% | 5,23 4,65 12.4% | 5,87 5,96 -1.54% | 6,20 6,28 -1.16% | 5,96 6,50 -8.37% | 6,33 6,30 0.35% | 5,35 6,32 -15.29% | 6,10 | 6,43 | 6,65 | 6,90 | 7,07 |
|
EBIT Million USD | Released Forecast Spread | -13,8 -15,4 10.45% | -18,4 -17,4 -5.82% | -15,0 -16,2 6.95% | -15,5 -15,8 1.92% | -16,8 -16,0 -5.16% | -19,5 -17,6 -11.29% | -17,8 -19,9 10.09% | -17,7 -18,5 4.29% | -19,5 -18,8 -4.05% | -19,0 | -19,4 | -19,3 | -20,9 | -21,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -13,9 -15,0 7.92% | -18,3 -17,3 -5.52% | -14,5 -16,1 10.2% | -13,9 -15,7 11.47% | -15,2 -15,9 4.19% | -18,0 -17,5 -2.58% | -16,3 -19,7 17.38% | -16,3 -18,0 9.48% | -18,3 -16,9 -8.53% | -18,0 | -18,5 | -18,4 | -20,4 | -21,4 |
|
Net income Million USD | Released Forecast Spread | -13,9 -15,0 7.92% | -18,3 -17,3 -5.57% | -14,5 -16,1 10.2% | -13,9 -15,7 11.52% | -15,2 -15,9 4.19% | -18,0 -17,5 -2.58% | -16,3 -19,7 17.38% | -16,3 -18,0 9.48% | -18,3 -16,9 -8.53% | -18,7 | -19,6 | -19,2 | -20,4 | -21,4 |
|
EPS USD | Released Forecast Spread | -0,66 -0,71 7.3% | -0,87 -0,80 -8.75% | -0,68 -0,74 8.36% | -0,48 -0,71 32.39% | -0,57 -0,62 7.57% | -0,67 -0,61 -10.74% | -0,60 -0,73 17.81% | -0,60 -0,65 7.41% | -0,68 -0,62 -9.68% | -0,66 | -0,61 | -0,62 | -0,73 | -0,76 |
| Announcement Date | 12/05/22 | 10/08/22 | 09/11/22 | 29/03/23 | 10/05/23 | 09/08/23 | 08/11/23 | 13/03/24 | 08/05/24 | - | - | - | - | - |
| 2024-07-11 02:00 am | BONESUPPORT HOLDING AB: Q2 2024 Earnings Release |
| 2024-07-15 | SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release |
| 2024-07-22 | BIOGEN INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 02:00 am | BIOGAIA AB: Q2 2024 Earnings Release |
| 2024-07-23 | SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | GRIFOLS, S.A.: Q2 2024 Earnings Release (Projected) |
| 2024-07-25 01:00 am | UCB: Q2 2024 Earnings Release |
| 2024-07-25 | SK BIOSCIENCE CO.,LTD.: Q2 2024 Earnings Release (Projected) |
| 2024-07-29 | BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Aadi Bioscience, Inc.
| 2024-05-14 11:35 am | GRIFOLS, S.A.: Q1 2024 Earnings Release |
| 2024-05-12 | ALTEOGEN INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-09 | PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release |
| 2024-05-09 | MEDY-TOX INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:05 pm | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:05 pm | ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 02:30 am | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
| 2024-05-08 | HUGEL, INC.: Q1 2024 Earnings Release |
| 2024-05-08 04:16 pm | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-08 04:05 pm | ZAI LAB LIMITED: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AADI Stock
- Calendar Aadi Bioscience, Inc.